Pages that link to "Q27024614"

The following pages link to A global approach to HIV-1 vaccine development (Q27024614):

Displaying 40 items.

• Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10 (Q21089590) (← links)
• A New Scientific Paradigm may be Needed to Finally Develop an HIV Vaccine (Q26830360) (← links)
• Mechanisms of HIV protein degradation into epitopes: implications for vaccine design (Q26866505) (← links)
• Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia. (Q30249677) (← links)
• An integrated map of HIV genome-wide variation from a population perspective. (Q30373040) (← links)
• Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3. (Q34046807) (← links)
• Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer (Q34059543) (← links)
• An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses. (Q34784825) (← links)
• Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development (Q35072515) (← links)
• Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon (Q35218117) (← links)
• HIV vaccine research: the challenge and the way forward (Q35227007) (← links)
• Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins (Q35488175) (← links)
• Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape. (Q35579689) (← links)
• Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env. (Q35641498) (← links)
• The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection (Q35686970) (← links)
• Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes (Q35745442) (← links)
• HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost (Q35883997) (← links)
• Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country (Q36144358) (← links)
• Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens (Q36434196) (← links)
• Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083 (Q36487887) (← links)
• Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and Denmark (Q36837324) (← links)
• Human Immunodeficiency Virus (HIV). (Q37045832) (← links)
• Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys (Q37355237) (← links)
• Broadly neutralizing antibodies and the promise of universal vaccines: where are we now? (Q38171571) (← links)
• HIV vaccines: a brief overview. (Q38210557) (← links)
• Decoding HIV resistance: from genotype to therapy (Q38632663) (← links)
• Lactobacillus plantarum displaying CCL3 chemokine in fusion with HIV-1 Gag derived antigen causes increased recruitment of T cells (Q38825666) (← links)
• Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition (Q38955637) (← links)
• Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health (Q40942917) (← links)
• Functional conservation of HIV-1 Gag: implications for rational drug design (Q41822002) (← links)
• Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein (Q42197619) (← links)
• Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development (Q42225514) (← links)
• Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells (Q45074789) (← links)
• Embracing the complexity of HIV immunology (Q46770038) (← links)
• Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors (Q58779740) (← links)
• Immune Correlate-Guided HIV Vaccine Design (Q59357079) (← links)
• Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India (Q60951055) (← links)
• Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus (Q64080897) (← links)
• HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers (Q91902646) (← links)
• Genetic Analysis of the Full-Length gag Gene from the Earliest Korean Subclade B of HIV-1: An Outbreak among Korean Hemophiliacs (Q92853339) (← links)